株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

冠動脈疾患向け医療機器の将来 2021年

The Future of Coronary Artery Disease Medical Devices to 2021

発行 Smithers Apex 商品コード 328441
出版日 ページ情報 英文 310 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
冠動脈疾患向け医療機器の将来 2021年 The Future of Coronary Artery Disease Medical Devices to 2021
出版日: 2015年02月19日 ページ情報: 英文 310 Pages
概要

2014年における世界のインターベンショナル心臓技術市場は、121億7,900万米ドルに達したと推計されています。同市場は今後9.1%のCAGRで推移し、2021年までに224億7,200万米ドルに拡大すると予測されています。

当レポートでは、世界の冠動脈疾患向け医療機器市場について調査し、疾患管理、市場の成長を促進する技術開発、詳細な地域分析、および主要企業のプロファイルなどをまとめ、お届けいたします。

エグゼクティブサマリー

イントロダクション・調査手法

心血管システム・冠動脈疾患のイントロダクション

  • 循環系
  • 心血管の生体構造・生理機能
    • 心臓
    • 心周期
    • 心臓の生理機能
    • 末梢血管系の構造
    • 冠動脈
  • 心血管疾患
    • 冠動脈疾患 (CAD)

冠動脈疾患管理

  • 疾患管理
    • 医療管理
    • ライフスタイルの変化
    • 医薬品
    • 外科的介入
    • ポートアクセスCABG (PACAB)
    • 経皮冠動脈インターベンション (PCI)
    • 冠動脈ステント挿入
    • 冠動脈性心疾患のその他の技術発展

冠動脈疾患に用いられるインターベンショナル心臓技術の世界市場

  • イントロダクション
  • 市場収益分析
    • 世界市場の収益分析
    • 世界市場の収益分析:地域別
    • 世界市場の収益分析:市場セグメント別
  • 市場シェア分析
    • 世界の市場シェア分析
    • 市場シェア分析:主な市場セグメント別

北米市場のレビュー・分析

  • イントロダクション
  • 規制・法的要件
  • 北米における診断・経皮冠動脈インターベンションの統計
  • 市場ダイナミクス
  • 市場収益分析
  • 市場シェア分析:市場セグメント別

欧州市場のレビュー・分析

アジア太平洋市場のレビュー・分析

中米・ラテンアメリカ市場のレビュー・分析

中東・アフリカ市場のレビュー・分析

企業プロファイル

図表リスト

目次

What does the report cover?

Cardiovascular disease (CVD) describes all diseases and conditions that relate to the heart and blood vessels. The global interventional cardiology technologies market reached an estimated $12,179 million in 2014. By 2021 it is predicted that this market will have further increased in value to $22,472 million with a compounded annual growth rate of 9.1%. Despite the issues and challenges confronting healthcare providers and players globally, this market remains buoyant and continues to provide improved quality of life for patients suffering from coronary artery disease. The Future of Coronary Artery Disease Medical Devices to 2021 examines the management of this disease and takes a close look at the technological developments that are driving this market including detailed geographical analysis and key company profiles.

What methodology is used?

The Future of Coronary Artery Disease Medical Devices to 2021 is based on extensive primary and secondary research. Primary research data on individual product and company sales has been gathered through interviews with manufacturers, end users, suppliers, distributors, and other relevant sources. These interviews typically included marketing managers, sales managers, distributor managers and owners, sales representatives as well as managers responsible for research and development (R&D). In addition interviews were conducted with senior managers amongst competing companies to determine the strategic direction and focus on the technological advances being made and the sales and marketing policies being adopted. Information was also obtained from numerous secondary data sources including many specialist associations and societies and numerous scientific publications as well as other sources of company revenue data.

What will you discover?

  • Insight into the key drivers and trends shaping the medical device market for Coronary Artery Disease
  • Close examination of the key geographical markets to help guide your business toward areas of growth

Who should buy this report?

  • Interventional cardiology device manufacturers
  • Stent manufacturers
  • Cardiac surgical device manufacturers
  • Venture capitalists and other investors

Table of Contents

Executive summary

Introduction and methodology

  • Introduction and background
  • Scope and report objectives
  • Methodology
  • Glossary of acronyms

Introduction to the cardiovascular systemand coronary artery diseases

  • The circulatory system
  • Cardiovascular anatomy and physiology
    • The Heart
    • The cardiac cycle
    • The physiology of the heart
    • Structure of the peripheral vascular system
    • The coronary arteries
  • Cardiovascular disease Conditions
    • Coronary artery disease (CAD)
      • Atherosclerosis
      • Angina pectoris
      • Myocardial infarction

Coronary artery disease management

  • Disease management
    • Medical management
    • Lifestyle changes
    • Pharmaceuticals
    • Surgical intervention
    • Port-access CABG (PACAB(G))
    • Percutaneous coronary interventions (PCIs)
    • Coronary stenting
    • Other technological developments for the treatment of coronary heart diseases

Summary global market for interventional cardiology technologies used to treat coronary artery disease

  • Introduction
  • Market revenue analysis
    • Global market revenue analysis
    • Global market revenue analysis by individual region
    • Global market revenue analysis by individual market segments
  • Market share analysis
    • Global market share analysis
    • Market share analysis by selected market segment

North America market review and analysis

  • Introduction
  • Regulatory and legislative requirements
    • US
    • Canada
  • Statistics on diagnostic and percutaneous coronary interventions in North America
  • Market dynamics
    • Market drivers
    • Market restraints
  • Market revenue analysis
    • Market revenue analysis (interventional cardiology)
    • Market revenue analysis by market segment
    • Market revenue analysis by selected individual country
  • Market share analysis by individual market segments

North America market review and analysis

  • Introduction
  • Regulatory and legislative requirements
    • US
    • Canada
  • Statistics on diagnostic and percutaneous coronary interventions in North America
  • Market dynamics
    • Market drivers
    • Market restraints
  • Market revenue analysis
    • Market revenue analysis (interventional cardiology)
    • Market revenue analysis by market segment
    • Market revenue analysis by selected individual country
  • Market share analysis by individual market segments

Europe market review and analysis

  • Introduction
  • Regulatory and legislative requirements
  • Statistics on coronary artery disease treatment procedures in Europe
  • Statistics on diagnostic and percutaneous coronary interventions in the European region
    • The Russian Federation
  • Market dynamics
    • Market drivers
    • Market restraints
  • Market revenue analysis
    • Market revenue analysis (interventional cardiology)
    • Market revenue analysis by market segment
    • Market revenue analysis by selected individual country
  • Market share analysis by individual market segments

Asia Pacific market review and analysis

  • Introduction
    • Japan
      • Regulatory and legislative requirements
      • Marketing authorization system
    • China
      • Overview of the healthcare system
      • Healthcare reforms
    • India
      • Overview of the healthcare system
    • South Korea
    • Specific issues affecting and influencing the stent market in the Asia Pacific region
  • Statistics on diagnostic and percutaneous coronary interventions in the Asia Pacific region
    • China
    • India
    • Japan
  • Other Asia Pacific countries
    • Market dynamics
    • Market drivers
    • Market restraints
      • China
      • India
      • Japan
  • Market revenue analysis
    • Market revenue analysis by market segment
    • Market revenue analysis by selected individual country
  • Market share analysis by individual market segments

Central and Latin America market review and analysis

  • Introduction
  • Brazil
    • Background
    • Regulatory and legislative requirements
    • Market entry and reimbursement of medical devices
    • Interventional cardiology in Brazil
  • Argentina
    • Background
    • Government-funded public health sector
    • Social health insurance sector
    • Private sector
    • Regulatory and legislative requirements
  • Mexico
    • Legislation and regulations governing medical devices in Mexico
    • Health insurance structure Mexico
    • Interventional Cardiology in Mexico
  • Statistics on diagnostic and percutaneous coronary interventions in the Central and Latin American region
    • Argentina
    • Brazil
    • Mexico
  • Market dynamics
    • Market drivers
    • Market restraints
  • Market revenue analysis
    • Market revenue analysis by market segment
    • Market revenue analysis by selected individual country
  • Central and Latin America: market share analysis by individual market segments
    • Saudi

Middle East Africa market review and analysis

  • Introduction
  • South Africa
    • Introduction to the healthcare system
    • Medical device regulatory requirements
    • Health insurance structure: South Africa
    • Reimbursement of medical devices
  • Saudi Arabia
    • The public healthcare system
    • Primary healthcare services
    • Secondary and tertiary healthcare services
    • The private healthcare sector
    • Medical device regulatory requirements
    • Health insurance structure
  • Statistics on diagnostic and percutaneous coronary interventions in the Middle East/Africa region
  • Market dynamics
    • Market drivers
    • Market restraints
    • Market revenue analysis by market segment
    • Market revenue analysis by selected individual country
  • Market share analysis by individual market segments

Company profiles Company addresses and contact details

Tables and figures

  • The Chinese healthcare system
  • Number of percutaneous coronary interventions (PCI) procedures in China: 1996-2013
  • Number of percutaneous coronary interventions (PCI) procedures in India: 2009-2012
  • Asia Pacific: revenue forecasts: interventional cardiology, 2011-2021
  • Asia Pacific: revenue forecasts: coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, 2011-2021
  • Asia Pacific: revenue forecasts: coronary stents, 2011-2021
  • Asia Pacific: revenue forecasts: vascular closure devices, 2011-2021
  • Central and Latin America: revenue forecasts: interventional cardiology, 2011-2021
  • Central and Latin America: revenue forecasts: coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, etc., 2011-2021
  • Central and Latin America: revenue forecasts: coronary stents, 2011-2021
  • Central and Latin America: revenue forecasts: vascular closure devices, 2011-2021
  • Current structure of the healthcare in Saudi Arabia 2012
  • Number of hospitals in Saudi Arabia and by supplier 2012
  • Middle East/Africa: revenue forecasts: interventional cardiology, 2011-2021
  • Middle East/Africa: revenue forecasts: coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, etc., 2011-2021
  • Middle East/Africa: revenue forecasts: coronary stents, 2011-2021
  • Middle East/Africa: revenue forecasts: vascular closure devices, 2011-2021
  • Structure and function of blood vessels
  • Comparison between arteries and veins
  • Europe, total cholesterol and high-cholesterol prevalence, selected MONICA project populations, by gender group
  • Ischemic heart disease, mortality rates, 2009 (or nearest year)
  • Standard angina pectoris classification
  • Currently available statins
  • Europe, selected pharmaceutical preparations prescribed for hospital patients with CHD, by geographic region (EUROASPIRE II, population survey)
  • Evaluation of ON-Pump CABG
  • Evaluation of OFF-Pump CABG
  • Structure of the heart
  • Anterior view of coronary arteries
  • Illustration of positions for port access
  • Global market: revenue forecasts: interventional cardiology, 2011-2021
  • Global market: revenue forecasts: interventional cardiology by region 2014
  • Global market: revenue forecasts, interventional cardiology, by individual segment 2014
  • Global market: revenue forecasts, interventional cardiology, by individual segment, coronary guidewires and accessories, etc. by geographic region 2014
  • Global market: revenue forecasts, interventional cardiology, by individual segment, coronary stents by geographic region 2014
  • Global market: revenue forecasts, interventional cardiology, by individual segment, vascular closure devices by geographic region 2014
  • Private health insurance coverage among persons under age 65: US, 2007-2011
  • Illustration of Medicare payment process
  • Trends in cardiovascular procedures, US: 1979-2010
  • North America: Revenue Forecasts: Interventional Cardiology, 2011-2021
  • North America: revenue forecasts: coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, etc., 2011-2021
  • North America: revenue forecasts: coronary stents, 2011-2021
  • Europe: revenue forecasts: vascular closure devices, 2011-2021
  • Number of coronary angiography and PCI procedures: Europe, 1999-2010
  • Femoral closure device utilization UK 2012
  • Europe: revenue forecasts: interventional cardiology, 2011-2021
  • Europe: revenue forecasts: coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, etc., 2011-2021
  • Europe: revenue forecasts: coronary stents, 2011-2021
  • Europe: revenue forecasts: vascular closure devices, 2011-2021
  • Coronary artery bypass graft surgery, procedure rates per 100,000 population, selected European countries
  • Comparison of different surgical methods
  • Currently available bare-metal coronary stent systems
  • Key clinical trials PCI and drugeluting stents
  • Global market: revenue forecasts: interventional cardiology, 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual region (North America) 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual region (Europe) 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual region (Asia Pacific) 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual region (Central and Latin America) 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual region (Middle East/ Africa) 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual segment, coronary guidewires, balloon dilatation catheters, guiding catheters and
  • accessories, 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual segment, coronary stents 2011-2021
  • Global market: revenue forecasts, interventional cardiology, by individual segment, vascular closure devices 2011-2021
  • Global market share analysis, interventional cardiology 2014
  • Global market share analysis, coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, 2014
  • Global market share analysis, coronary stents, 2014
  • Global market share analysis, vascular closure devices, 2014
  • Personal healthcare expenditures; aggregate and per capita amounts, percent distribution and annual percent change by source of funds: calendar years 2006-2018 ($
  • billion)
  • ICD-9-cm diagnosis codes commonly used to report cardiac conditions
  • ICD-9-cm common ICD-9-cm procedure codes - cardiovascular interventional procedures: coronary vessels
  • Common MS-DRGS for coronary procedures
  • Coronary interventions CPT procedure codes US 2014
  • Total coronary diagnostic and treatment procedures billed in the medicare population from 2005-2009
  • Projections of crude CVD prevalence % 2010-2030 in the US
  • Reasons for decline in number of percutaneous coronary interventions in the US
  • National medicare fees for common invasive and interventional procedures
  • North America: revenue forecasts: interventional cardiology, 2011-2021
  • Revenue forecasts: coronary guide wires, balloon dilatation catheters, guiding catheters and accessories, 2011-2021 Revenue forecasts: coronary stents, 2011-2021 Revenue forecasts: vascular closure devices, 2011-2021 Market share analysis, interventional cardiology (2014) Market share analysis, coronary guide wires, balloon dilatation catheters, guiding catheters and accessories (2014) Market share analysis, coronary stents (2014) Market share analysis, vascular closure devices (2014)
  • North America
  • Europe
  • Asia Pacific
  • Central and Latin America
  • Middle East/Africa
  • Revenue analysis
  • North America
  • US, 2011-2021
  • Canada, 2011-2021
  • Europe
  • France, 2011-2021
  • Germany, 2011-2021
  • Italy, 2011-2021
  • Spain, 2011-2021
  • UK, 2011-2021
  • Benelux, 2011-2021
  • Asia Pacific
  • China, 2011-2021
  • India, 2011-2021
  • Japan, 2011-2021
  • Central and Latin America
  • Brazil, 2011-2021
  • Argentina, 2011-2021
  • Mexico, 2011-2021
  • Middle East/Africa
  • Africa, 2011-2021
  • Middle East, 2011-2021
  • Range of stent technology procedure codes Germany 2004-2011
  • Number of conventional coronary artery bypass graft (CABG) procedures: Europe, 2011-2018
  • Number of off-pump coronary artery bypass (OPCAB) procedures: Europe, 2011-2018
  • Number of minimally invasive direct coronary artery bypass (MIDCAB) procedures: Europe, 2011-2018
  • UK interventional and diagnostic centres and number of PCI procedures 2012
  • Overview of pharmaceutical affairs law (PAL) and Japanese medical devices nomenclature (JMDN) codes and related codes according to the EU MDD
  • Reimbursement categories: Japan
  • Number of healthcare institutions according to ownership China, 2010
  • Total number of hospitals by ranking China, 2010
  • Overview of healthcare in India
  • Health facilities South Africa
  • Abbott laboratories financial figures 2011-2013
  • Boston scientific financial figures 2011-2013
  • Biosensors international financial figures 2012-2013 revenues by product segment $'000s
  • Biosensors international financial figures 2012-2013 revenues by geographic region $'000s
  • Johnson & Johnson financial figures, medical devices and diagnostics segment, 2011- 2013 revenues by product segment
  • Medtronic financial figures, 2012-2014 revenues by product segment
Back to Top